PANTHER: AZD8931, inhibitor of EGFR, ERBB2 and ERBB3 signalling, combined with FOLFIRI: a Phase I/II study to determine the importance of schedule and activity in colorectal cancer
- Publication date
- 9 November 2022
- Publisher
- 'Springer Science and Business Media LLC'